PurpleLab

PurpleLab Boosts Pharma Ads with Strategic Partnerships

PurpleLab, a healthcare analytics company, has formed strategic partnerships with Experian, DeepIntent, InsightsRx, and Comscore to enhance pharmaceutical advertising capabilities. These partnerships are designed to provide scale, precision, and privacy-conscious targeting, alongside real-time measurement for advertisers. PurpleLab's dataset, including de-identified patient data and provider claims, now complements each partner's strengths, allowing advertisers to optimize audience activation and media buying. This initiative addresses the rising pharmaceutical advertising spend and navigates challenges like privacy regulation and media fragmentation. Each partnership offers unique benefits, such as Experian's identity resolution, DeepIntent's higher audience quality, InsightsRx's real-time optimization tools, and Comscore's privacy-centric data solutions.

Healthcare TV Ads Shift: Embrace CTV Over Linear

TV advertising in healthcare is undergoing a decisive shift as audiences migrate from traditional linear TV to connected TV (CTV) and streaming. The piece argues that TV’s core advantages—broad reach and low cost per impression—are eroding. Since 2019, more than 30 million households left traditional cable, and though 68 million households remain, CTV viewership in 2024 surpassed linear by about 2 million (233.9M vs. 232.3M). CTV can be integrated into omnichannel strategies with data-driven attribution, whereas linear’s reach often comes with higher hidden costs. When comparing costs, linear CPMs run roughly $10-15, while CTV CPMs are $20-35; accounting for viewability waste (roughly 30% on linear) and frequency/audience inefficiencies, linear can cost about three times more per 1,000 impressions. For healthcare, CTV enables more precise targeting but may require fewer impressions at a higher price. PurpleLab is highlighted as a partner to enhance CTV targeting and pre-campaign analysis.

AI Revolutionizes HIPAA Compliance for Health Care Marketing

Health care marketers face stiff HIPAA constraints that complicate data segmentation and drive up deidentification costs, limiting the size and freshness of audience analytics. The article argues that the traditional manual deidentification workflow is slow and expensive, creating a bottleneck for timely insights. It proposes AI as a solution to accelerate data cleaning, deidentification, and preparation for analytics, enabling faster production of HIPAA-compliant datasets and broader data use. A notable data source is health care claims data, with PurpleLab estimating 50 to 60 billion claims over the last decade, which AI could help parse at scale. PurpleLab claims to have developed an AI toolkit that addresses both deidentification and interpretation of health care claims data, enabling marketers and their agencies and ad-tech partners to index by condition or prescribing behavior. The piece advocates democratizing access to HIPAA-compliant claims data via intuitive tools, so non-analysts can contribute to audience modeling while preserving privacy.